November is dedicated to Chronic Obstructive Pulmonary Disease (COPD) Awareness, and its purpose is to educate about the causes and management of COPD, as well as diminish the stigma associated with respiratory conditions and encourage early intervention.
COPD is a type of progressive lung disease characterized by long-term respiratory symptoms and airflow limitation. It is a leading cause of morbidity and mortality globally. Millions are affected, and the numbers continue to rise. With smoking and environmental factors playing a significant role, knowledge becomes a powerful tool in prevention.
Risk factors could include tobacco exposure, exposure to pollutants and irritants in the air (such as industrial fumes), history of childhood respiratory infections, and genetic conditions.
Recognizing symptoms like chronic cough, shortness of breath, and wheezing is key. Early detection enables timely interventions to slow disease progression and enhance the quality of life.
Treatment options could include medications, oxygen therapy, pulmonary rehabilitation, surgery, and lifestyle modifications.
Contact us at bd@gctrials.com to learn more about GCT’s experience in COPD studies and clinical trials.